7 studies found for:    17975015 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Optimising Renal Outcome in Myeloma Renal Failure
Conditions: Multiple Myeloma;   Chronic Kidney Disease
Interventions: Drug: Bortezomib;   Drug: Thalidomide;   Drug: Bendamustine;   Drug: Dexamethasone
2 Withdrawn Imaging Studies and the Development of Multiple Myeloma
Conditions: Multiple Myeloma;   Smoldering Multiple Myeloma;   Monoclonal Gammopathy of Undetermined Significance
Intervention: Drug: Fluciclatide
3 Completed Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
Conditions: Smoldering Myeloma;   Monoclonal Gammopathy of Undetermined Significance
Intervention:
4 Not yet recruiting Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients
Condition: Multiple Myeloma
Intervention: Drug: Filanesib, pomalidomide and dexamethasone
5 Completed
Has Results
Imaging in MGUS, SMM and MM
Conditions: Multiple Myeloma;   Smoldering Multiple Myeloma;   Monoclonal Gammopathy of Undetermined Significance
Interventions: Drug: 18-NaF PET;   Other: DCE-MRI;   Drug: 18-FDG PET/CT
6 Enrolling by invitation Exercise in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Other: Exercise
7 Active, not recruiting Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib;   Drug: Lenalidomide;   Drug: Dexamethasone

Indicates status has not been verified in more than two years